Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf-Karsten Hofmann

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 11, 2017
[Not Available]Florian Nolte, Wolf-Karsten Hofmann
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Current Clinical Practice: Current Therapeutic Options in Myelodysplastic SyndromesWOLF-KARSTEN Hofmann, DIETER Hoelzer
Deutsche Medizinische Wochenschrift (1946)|December 1, 2016
[Antifungal medication: new substances, new experiences]Dieter Buchheidt, Wolf-Karsten Hofmann
Expert Review of Anticancer Therapy|September 24, 2013
Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical results and open questionsEva Lengfelder, Wolf-Karsten Hofmann, Daniel Nowak
Annals of Hematology|May 23, 2013
Management of elderly patients with acute promyelocytic leukemia: progress and problemsEva Lengfelder, Wolf-Karsten Hofmann, Florian Nolte
Deutsche Medizinische Wochenschrift (1946)|February 7, 2018
[Acute Promyelocytic Leukemia - A Rare, Life-Threatening Disease with High Healing Chance]Florian Nolte, Eva Lengfelder, Wolf-Karsten Hofmann
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 5, 2010
Genome-wide Mapping of Copy Number Variations Using SNP ArraysDaniel Nowak, Wolf-Karsten Hofmann, H Phillip Koeffler
International Journal of Cancer|August 13, 2022
Therapy resistance mechanisms in hematological malignanciesWolf-Karsten Hofmann, Andreas Trumpp, Carsten Müller-Tidow
British Journal of Haematology|February 26, 2013
Globular intracytoplasmic inclusions in a patient with chronic lymphocytic leukaemiaGeorgia Metzgeroth, Sven Schneider, Wolf-Karsten Hofmann, et al.
Biomarker Insights|April 30, 2016
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase InhibitorsMark Reinwald, Tobias Boch, Wolf-Karsten Hofmann, et al.
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
Deutsche Medizinische Wochenschrift (1946)|October 11, 2017
[Not Available]Florian Nolte, Wolf-Karsten Hofmann
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Current Clinical Practice: Current Therapeutic Options in Myelodysplastic SyndromesWOLF-KARSTEN Hofmann, DIETER Hoelzer
Deutsche Medizinische Wochenschrift (1946)|December 1, 2016
[Antifungal medication: new substances, new experiences]Dieter Buchheidt, Wolf-Karsten Hofmann
Expert Review of Anticancer Therapy|September 24, 2013
Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical results and open questionsEva Lengfelder, Wolf-Karsten Hofmann, Daniel Nowak
Annals of Hematology|May 23, 2013
Management of elderly patients with acute promyelocytic leukemia: progress and problemsEva Lengfelder, Wolf-Karsten Hofmann, Florian Nolte
Deutsche Medizinische Wochenschrift (1946)|February 7, 2018
[Acute Promyelocytic Leukemia - A Rare, Life-Threatening Disease with High Healing Chance]Florian Nolte, Eva Lengfelder, Wolf-Karsten Hofmann
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 5, 2010
Genome-wide Mapping of Copy Number Variations Using SNP ArraysDaniel Nowak, Wolf-Karsten Hofmann, H Phillip Koeffler
International Journal of Cancer|August 13, 2022
Therapy resistance mechanisms in hematological malignanciesWolf-Karsten Hofmann, Andreas Trumpp, Carsten Müller-Tidow
British Journal of Haematology|February 26, 2013
Globular intracytoplasmic inclusions in a patient with chronic lymphocytic leukaemiaGeorgia Metzgeroth, Sven Schneider, Wolf-Karsten Hofmann, et al.
Biomarker Insights|April 30, 2016
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase InhibitorsMark Reinwald, Tobias Boch, Wolf-Karsten Hofmann, et al.
Pageof 28